COMP <GO>
INGR vs FRPT // NET PROFIT MARGIN
Ingredion Incorporated (NYSE) VS. Freshpet Inc. (NASDAQ) • 15-METRIC TALLY: INGR 7
— FRPT 6
▲ NET PROFIT MARGIN LEADER: FRPT
LAST: $98.93 (+2.02%) • MKT CAP: $6.12B
net-margins
10.10%
LAST: $69.62 (+3.14%) • MKT CAP: $3.24B
net-margins
12.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INGR VS. FRPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INGR | FRPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | 40.80% | -15.50 | FRPT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.10% | 6.40% | +9.70 | INGR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.9x | 38.3x | -33.40 | INGR | /valuation <GO> |
| Free Cash Flow Yield | 8.48% | 5.05% | +3.43 | INGR | /fcf-yield <GO> |
| Operating Margin | 14.10% | 6.90% | +7.20 | INGR | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 10.10% | 12.60% | -2.50 | FRPT | /net-margins <GO> |
| Revenue Growth (YoY) | -2.80% | 13.00% | -15.80 | FRPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.50% | 0.00% | +3.50 | INGR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.69 | 4.24 | -0.55 | FRPT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | FRPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.9 | 57.4 | -5.50 | FRPT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 7.7x | 19.2x | -11.50 | INGR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.12B | $3.24B | $2.87B | INGR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INGR REV | FRPT REV | INGR GROSS % | FRPT GROSS % | INGR FCF | FRPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.22B | $1.10B | 25.3% | 40.8% | $511.0M | $160.6M |
| FY 2024 | $7.43B | $975.2M | 24.1% | 40.6% | $1.14B | $154.3M |
| FY 2023 | $8.16B | $766.9M | — | — | $689.8M | $75.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INGR // BETA 1.16
FRPT // BETA —